1. Home
  2. CNTX vs SLNG Comparison

CNTX vs SLNG Comparison

Compare CNTX & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • SLNG
  • Stock Information
  • Founded
  • CNTX 2015
  • SLNG 2013
  • Country
  • CNTX United States
  • SLNG United States
  • Employees
  • CNTX N/A
  • SLNG N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • SLNG Oil/Gas Transmission
  • Sector
  • CNTX Health Care
  • SLNG Utilities
  • Exchange
  • CNTX Nasdaq
  • SLNG Nasdaq
  • Market Cap
  • CNTX 75.6M
  • SLNG 88.9M
  • IPO Year
  • CNTX 2021
  • SLNG N/A
  • Fundamental
  • Price
  • CNTX $1.26
  • SLNG $4.78
  • Analyst Decision
  • CNTX Strong Buy
  • SLNG Strong Buy
  • Analyst Count
  • CNTX 7
  • SLNG 1
  • Target Price
  • CNTX $5.20
  • SLNG $10.00
  • AVG Volume (30 Days)
  • CNTX 500.2K
  • SLNG 12.3K
  • Earning Date
  • CNTX 11-10-2025
  • SLNG 11-05-2025
  • Dividend Yield
  • CNTX N/A
  • SLNG N/A
  • EPS Growth
  • CNTX N/A
  • SLNG N/A
  • EPS
  • CNTX N/A
  • SLNG 0.05
  • Revenue
  • CNTX N/A
  • SLNG $69,572,000.00
  • Revenue This Year
  • CNTX N/A
  • SLNG $4.10
  • Revenue Next Year
  • CNTX N/A
  • SLNG $11.10
  • P/E Ratio
  • CNTX N/A
  • SLNG $99.61
  • Revenue Growth
  • CNTX N/A
  • SLNG N/A
  • 52 Week Low
  • CNTX $0.49
  • SLNG $3.29
  • 52 Week High
  • CNTX $2.46
  • SLNG $8.28
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 56.22
  • SLNG 53.79
  • Support Level
  • CNTX $1.19
  • SLNG $4.70
  • Resistance Level
  • CNTX $1.50
  • SLNG $4.93
  • Average True Range (ATR)
  • CNTX 0.15
  • SLNG 0.19
  • MACD
  • CNTX -0.02
  • SLNG -0.03
  • Stochastic Oscillator
  • CNTX 39.78
  • SLNG 17.71

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: